Primary Job Title Founder, Chief Executive Officer & President Primary Organization 
Indalo Therapeutics
Location St Louis, Missouri, United States Regions Midwestern US Gender Male
Investor Type Number of Exits
LinkedIn View on LinkedIn
Robert Karr has broad experience in the drug discovery and development process, including discovery/preclinical research, IND preparation, interactions with the FDA, the design and conduct of clinical trials, and investor relations. He currently serves as CSO of Tioma Therapeutics and previously served as President & CEO of Indalo (then
called Antegrin Therapeutics) from 2012-2015. Prior roles have included President of Idera Pharmaceuticals, Senior Vice President of Strategic Management at Pfizer, and Vice President of Research and Development Strategy at Warner-Lambert. Dr. Karr received his B.S. (Honors) from Southwestern University in 1971 and his M.D (with highest honors) from the University of Texas Medical Branch in 1975.
